Gossamer Bio, Inc.
GOSS
$1.14
-$0.115-9.20%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.73% | -8.48% | -13.10% | -5.58% | -29.43% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.60% | 7.18% | -5.47% | -12.45% | -28.18% |
| Operating Income | 7.43% | 16.23% | 212.54% | 12.45% | 28.18% |
| Income Before Tax | 26.40% | 20.18% | 226.29% | 14.72% | 13.66% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 31.40% | 23.01% | 215.85% | 14.72% | 13.66% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 31.40% | 23.01% | 215.85% | 14.72% | 13.66% |
| EBIT | 7.43% | 16.23% | 212.54% | 12.45% | 28.18% |
| EBITDA | 7.01% | 15.96% | 214.22% | 12.14% | 28.11% |
| EPS Basic | -36.47% | 34.38% | 148.88% | 64.16% | 63.89% |
| Normalized Basic EPS | -102.65% | 31.94% | 153.31% | 62.71% | 65.16% |
| EPS Diluted | -36.47% | 34.38% | 148.20% | 63.46% | 63.89% |
| Normalized Diluted EPS | -102.65% | 31.94% | 150.54% | 62.71% | 65.16% |
| Average Basic Shares Outstanding | 0.53% | 17.35% | 137.01% | 137.94% | 139.08% |
| Average Diluted Shares Outstanding | 0.53% | 17.35% | 149.92% | 137.94% | 139.08% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |